Second Circuit Ruling Rejects Flawed Autism Science in Pharmaceutical Lawsuits
In a recent legal development, the United States Court of Appeals for the Second Circuit has affirmed the exclusion of purported autism science, aiming to discredit its usage in lawsuits connected to this neurological disorder. The case in question, Daniels-Feasel v. Forest Pharms., Inc., 2023 U.S. App. LEXIS 19448 (2d Cir. July 28, 2023), seems…